Cite
HARVARD Citation
Sánchez-Conde, M. et al. (2022). Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study. International journal of infectious diseases. pp. 97-103. [Online].